Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, Davis, CA, USA.
Clin Rev Allergy Immunol. 2012 Aug;43(1-2):30-44. doi: 10.1007/s12016-011-8274-y.
Status asthmaticus (SA) is defined as an acute, severe asthma exacerbation that does not respond readily to initial intensive therapy, while near-fatal asthma (NFA) refers loosely to a status asthmaticus attack that progresses to respiratory failure. The in-hospital mortality rate for all asthmatics is between 1% to 5%, but for critically ill asthmatics that require intubation the mortality rate is between 10% to 25% primarily from anoxia and cardiopulmonary arrest. Timely evaluation and treatment in the clinic, emergency room, or ultimately the intensive care unit (ICU) can prevent the morbidity and mortality associated with respiratory failure. Fatal asthma occurs from cardiopulmonary arrest, cerebral anoxia, or a complication of treatments, e.g., barotraumas, and ventilator-associated pneumonia. Mortality is highest in African-Americans, Puerto Rican-Americans, Cuban-Americans, women, and persons aged ≥ 65 years. Critical care physicians or intensivists must be skilled in managing the critically ill asthmatics with respiratory failure and knowledgeable about the few but potentially serious complications associated with mechanical ventilation. Bronchodilator and anti-inflammatory medications remain the standard therapies for managing SA and NFA patients in the ICU. NFA patients on mechanical ventilation require modes that allow for prolonged expiratory time and reverse the dynamic hyperinflation associated with the attack. Several adjuncts to mechanical ventilation, including heliox, general anesthesia, and extra-corporeal carbon dioxide removal, can be used as life-saving measures in extreme cases. Coordination of discharge and follow-up care can safely reduce the length of hospital stay and prevent future attacks of status asthmaticus.
哮喘持续状态(SA)定义为急性、严重的哮喘加重,对初始强化治疗反应不佳,而濒死性哮喘(NFA)则泛指进展为呼吸衰竭的哮喘持续状态发作。所有哮喘患者的院内死亡率在 1%至 5%之间,但需要插管的重症哮喘患者死亡率在 10%至 25%之间,主要是由于缺氧和心肺骤停。在诊所、急诊室或最终在重症监护病房(ICU)及时进行评估和治疗,可以预防与呼吸衰竭相关的发病率和死亡率。致死性哮喘是由心肺骤停、脑缺氧或治疗并发症引起的,例如气压伤和呼吸机相关性肺炎。在非裔美国人、波多黎各裔美国人、古巴裔美国人、女性和≥65 岁的人群中死亡率最高。重症监护医生或重症监护专家必须熟练掌握管理呼吸衰竭的重症哮喘患者,并了解与机械通气相关的少数但潜在严重的并发症。支气管扩张剂和抗炎药物仍然是管理 ICU 中 SA 和 NFA 患者的标准治疗方法。接受机械通气的 NFA 患者需要允许延长呼气时间并逆转与发作相关的动态过度充气的模式。几种机械通气的辅助手段,包括氦氧混合气、全身麻醉和体外二氧化碳去除,可以作为极端情况下的救生措施。协调出院和随访护理可以安全地缩短住院时间并预防未来的哮喘持续状态发作。